
Loading...

Applications for licenses pertaining to recombinant DNA (r-DNA) medications must now only be submitted with the help of the Online National Medications Licensing System (ONDLS) portal, according to a recent regulation change from the Central Drugs Standard Control Organization (CDSCO).
About the Author

Anshika Jindal, a Legal Content Writer with strong expertise in legal research and a solid academic background in BA LLB and LLM (Criminal Law). I specialize in researching statutes, case laws, and legal developments and presenting them in clear, accurate, and engaging written content. With strong analytical skills and attention to detail, I create reliable, well-structured legal content while maintaining professional and ethical standards.
I specialize in conducting in-depth legal research using credible sources and presenting legal information in a structured, reader-friendly manner while maintaining precision and authenticity. My work focuses on simplifying legal language without compromising its meaning, making legal content accessible to a wider audience.
Related articles

CDSCO Drug License Approval in India: Full Process 2026
2026-04-22

New Drug Manufacturing and Clinical Trial Rules Updated in 2026: What You Should Know?
2026-03-13

CDSCO Releases New Guidelines for Compounding of Offences Under the Drugs and Cosmetics Act
2026-02-26

Regulation of Medical Device Pricing and Quality in India: Key Government Measures
2026-02-20

CDSCO Releases Risk Classification List for Oncology Medical Devices
2026-02-12

Government Notifies CGHS Drug Procurement Policy 2026
2026-01-24
How to Get Pollution NOC from the State Pollution Control Board?
2026-04-29 • 0 views
2023-02-27
FSSAI Limits Ashwagandha Use to Roots and Extracts Only
2026-04-22